Ray Therapeutics, Inc.
Clinical trials sponsored by Ray Therapeutics, Inc., explained in plain language.
-
Gene therapy injection aims to save sight in rare eye disease
Disease control Recruiting nowThis early-stage trial tests a single injection of a gene therapy called RTx-021 in the eye of people with Stargardt disease, a genetic condition that causes vision loss. Up to 18 participants will receive different doses to check safety and tolerability. Researchers will monitor…
Phase: PHASE1, PHASE2 • Sponsor: Ray Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New study aims to sharpen vision tests for the blind
Knowledge-focused Recruiting nowThis study enrolls 25 people with severe retinal diseases like retinitis pigmentosa and Stargardt disease to test new ways of measuring visual function. Researchers will evaluate how well participants can perform various vision tests, such as navigating obstacles or detecting lig…
Sponsor: Ray Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC